EU project starts work on world's largest dyslexia databank

A new EU-funded project is aiming to create the world's largest databank on dyslexia. Dyslexia is a common learning disorder that affects at least 5% of school children in Europe. The range and severity of the problem varies widely, but the main areas of difficulty are reading, writing, spelling, numeracy, personal organisation and time-keeping. The degree to which individuals may be affected ranges from mild spelling difficulties to severe organisational problems or complete illiteracy.

"Dyslexia is a huge societal problem, affecting one out of five children in Europe," says Franck Ramus of the French National Centre for Scientific Research (CNRS). "Although not as widespread compared to other diseases, it presents a major handicap to those that suffer from it."

CNRS is one of 13 partnering organisations from nine European countries involved in NEURODYS, a project funded under the "Life sciences, genomics and biotechnology for health" section of the Sixth Framework Programme (FP6). The purpose is to determine the biological and environmental factors involved in the disease.

"There's been a lot of research on dyslexia over the last 30 years, mainly on a cognitive and brain basis," told Dr Ramus. Neurological research suggests dyslexia is caused by some abnormality in the function of the left side of the brain which controls the lexical system, whereas cognitive research in recent years has increasingly focused on problems of phonological awareness - the awareness of the speech sounds within words. This has led to some speculation that these problems may be associated with a specific area of the brain. However, much of the research has been inconclusive.

"The NEURODYS project will also study dyslexia from the cognitive and brain basis but the main emphasis will be on its genetic basis," said Dr Ramus. "Although there has been some preliminary work done on dyslexia in the field of genetics, it was only with the mapping of the human genome in 2003, that real molecular studies on dyslexia could start." Specifically, the project will explore the links between the underlying active brain regions and risk-conferring genes.

One of the challenges of conducting a pan-European genetics study on dyslexia is the exceptionally large dataset required. Over a three-year period, the project aims to collect samples from a total of 4,000 children, coming from different countries across Europe to allow researchers to take into account language and environmental specificities.

A total of 2,000 samples have been collected so far and work has begun to develop a database. "This will be the world's largest databank," said Dr Ramus, who expects to see it get even bigger in the months to come. "There is mounting interest by US research groups to merge with us and create a transatlantic project on dyslexia."

By integrating new data at the molecular, cerebral and behavioural levels from across the different countries, the project partners expect to gain a deeper insight into which aspects of dyslexia are universal, and which are specific to each language. It will also enable scientists to establish a solid basis for improving diagnosis and treatment.

For further information, please visit:

  • http://www.neurodys.com
  • http://cordis.europa.eu/lifescihealth/home.html

    Copyright ©European Communities, 2006
    Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Researchers Invent AI Model to Design Ne…

Researchers at McMaster University and Stanford University have invented a new generative artificial intelligence (AI) model which can design billions of new antibiotic molecules that are inexpensive and easy to...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Greater Manchester Reaches New Milestone…

Radiologists and radiographers at Northern Care Alliance NHS Foundation Trust have become the first in Greater Manchester to use the Sectra picture archiving and communication system (PACS) to report on...

Powerful New AI can Predict People'…

A powerful new tool in artificial intelligence is able to predict whether someone is willing to be vaccinated against COVID-19. The predictive system uses a small set of data from demographics...

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...